Table 2 Procedural details
Procedural details | BVS & DCB group (n = 40) |
|---|---|
Access site | |
Radial | 32 (80%) |
Femoral | 8 (20%) |
LM diseased | 1 (2.5%) |
LAD diseased | 23 (57.5%) |
LCX diseased | 11 (27.5%) |
RCA diseased | 8 (20%) |
Syntax score | 15.04 ± 7.18 |
Medina class | |
1,1,1 | 27(67.5%) |
1,1,0 | 0(0%) |
1,0,1 | 0% |
0,1,1 | 9 (22.5%) |
0,1,0 | 1 (2.5%) |
1,0,0 | 1 (2.5%) |
0,1,1 | 2 (5%) |
OCT | 3 (7.5%) |
IVUS | 10 (25%) |
ACC/AHA | |
A | 0% |
B1 | 2 (5%) |
B2 | 34 (85%) |
C | 4 (10%) |
Denovo lesions | 100% |
ISR | 0% |
Thrombus | 5 (2.5%) |
CTO | 6 (15%) |
RVD (proximal MV) (mm) | 3.13 ± 0.4 |
Lesion length (MV) (mm) | 21.42 ± 16.25 |
RVD SB (mm) | 2.31 ± 0.34 |
MLD MV (mm) | 0.51 ± 0.37 |
MLD SB (mm) | 0.77 ± 0.62 |
Lesion length (SB) (mm) | 11.49 ± 6.35 |
% stenosis MV | 83.2 ± 13.4% |
% stenosis SB | 66.79 ± 24% |
Predilatation MV | 40 (100%) |
Predilatation MV balloon diameter | 2.81 ± 0.45 m |
Predilatation pressure (atm) | 13 ± 0.36 |
Scoring balloon MV | 1 (2.5%) |
Rotablator MV | 0% |
Type of BVS | Absorb (100%) |
Length BVS (mm) | 22.02 ± 6.07 |
Second BVS used | 7 (17.5%) |
Inflation pressure BVS (atm) | 10.92 ± 1.4 atm |
Post dilatation of BVS | 40 (100%) |
Post dilatation balloon diameter (mm) | 3.31 ± 0.39 |
Inflation pressure of postdilatation balloon (atm) | 20.3 ± 4.4 |
Predilatation SB | 32 (80%) |
KB before stent implantation | 5 (12.5%) |
Kissing balloon inflation | 23(57.5%) |
Predilatation of SB balloon diameter | 2.25 ± 0.33 |
Predilatation SB balloon inflation pressure | 11 ± 3 atm |
Type of DCB used | |
Pantera Lux | 6 (15%) |
Elutax SV | 11 (27.5%) |
Restore | 6 (15%) |
Sequent please | 4 (10%) |
In.Pact Falcon | 10 (25%) |
Danubu | 1 (2.5%) |
Agent | 1(2.5%) |
Magic | 1 (2.5%) |
Diameter of DCB | 2.43 ± 0.37 mm |
DCB length | 20.36 ± 6.42 mm |
DCB inflation pressure | 9.4 ± 1.9 atm |
DCB inflation duration | 52 ± 10 sec |
FKB with normal balloons | 6 (15%) |
FKB with DCB | 17 (42.5%) |
Dissection left after DCB | 6 (15%) |
Type of dissections | |
A | 5 (12.5%) |
C | 1 (2.5%) |
Stenting of SB | 0% |
Final % diameter stenosis MB | 5.3 ± 8% |
Final % diameter stenosis SB | 13.0 ± 16.4% |
Final MLD MB (mm) | 3.0 ± 0.43 mm |
Final MLD SB (mm) | 1.9 ± 0.5 mm |
Total amount of contrast (ml) | 212 ± 117 |
Procedural time (min) | 71.8 ± 38 min |
Total fluoroscopy time (min) | 12 ± 3.9 min |
BVS/DES-related complications | 0% |
BVS underexpansion | 0% |
Longitudinal deformation | 0% |
BVS recoil | 0% |
Final TIMI less than 3 | 0% |
Intraprocedural occlusiom | 0% |
Intraprocedural death | 0% |
Peri-procedural MI | 0% |
Medications at discharge | |
Aspirin | 40(100%) |
Clopidogrel | 11(27.5%) |
Prasugrel | 4 (10%) |
Ticagrelor | 25(62.5%) |